{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:37:40Z","timestamp":1792532260808,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gasdermin D (GSDMD) is a critical pyroptosis mediator, consisting of one N-terminal pore-forming domain and one C-terminal auto-inhibitory domain. The free N-terminal domain (GD-NT), which is released through caspase-1\/11 cleavage, exhibits distinct features from the full-length GSDMD (GD-FL), including oligomerization, membrane translocation, and pore-formation. However, the underlying mechanisms are not well elucidated. Here, we found that GD-NT, but not GD-FL, was massively ubiquitinated in cells. The K63-linked polyubiquitination of GD-NT at Lys236\/237 (human\/mouse), catalyzed by TRAF1, directly prompted its membrane translocation and pore-formation during pyroptosis. Inhibition of GD-NT ubiquitination via site-directed mutations or the UBA1 inhibitor PYR-41 suppressed cell death in several pyroptosis cell models. Additionally, applying PYR-41 in septic mice efficiently suppressed the release of IL-18 and TNF\u03b1. Thus, GD-NT ubiquitination is a key regulatory mechanism controlling its membrane localization and activation, which may provide a novel target for modulating immune activity in pyroptosis-related diseases.<\/jats:p>","DOI":"10.1038\/s41419-025-07475-6","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:40:10Z","timestamp":1742218810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ubiquitination of gasdermin D N-terminal domain directs its membrane translocation and pore formation during pyroptosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4878-5834","authenticated-orcid":false,"given":"Xiufeng","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-1840","authenticated-orcid":false,"given":"Ihtisham","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"7475_CR1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.","journal-title":"Signal Transduct Target Ther"},{"key":"7475_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature12940","volume":"505","author":"G Doitsh","year":"2014","unstructured":"Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014;505:509\u201314.","journal-title":"Nature"},{"key":"7475_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"7475_CR4","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12:4310\u201329.","journal-title":"Theranostics"},{"key":"7475_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711939","volume":"12","author":"X Zheng","year":"2021","unstructured":"Zheng X, Chen W, Gong F, Chen Y, Chen E. The role and mechanism of pyroptosis and potential therapeutic targets in sepsis: a review. Front Immunol. 2021;12:711939.","journal-title":"Front Immunol"},{"key":"7475_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10875-019-00638-z","volume":"39","author":"LM Booshehri","year":"2019","unstructured":"Booshehri LM, Hoffman HM. CAPS and NLRP3. J Clin Immunol. 2019;39:277\u201386.","journal-title":"J Clin Immunol"},{"key":"7475_CR7","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/ng.3089","volume":"46","author":"SW Canna","year":"2014","unstructured":"Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y, et al. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014;46:1140\u20136.","journal-title":"Nat Genet"},{"key":"7475_CR8","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2021.27","volume":"23","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, Chen L, Gu H, He X, Ye Z, Wang Z, et al. GSDMD-mediated pyroptosis: a critical mechanism of diabetic nephropathy. Expert Rev Mol Med. 2021;23:e23.","journal-title":"Expert Rev Mol Med"},{"key":"7475_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3389\/fphys.2017.00519","volume":"8","author":"B Luo","year":"2017","unstructured":"Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke H, et al. NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy. Front Physiol. 2017;8:519.","journal-title":"Front Physiol"},{"key":"7475_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jcp.30627","volume":"237","author":"P Miao","year":"2022","unstructured":"Miao P, Ruiqing T, Yanrong L, Zhuwen S, Huan Y, Qiong W, et al. Pyroptosis: A possible link between obesity-related inflammation and inflammatory diseases. J Cell Physiol. 2022;237:1245\u201365.","journal-title":"J Cell Physiol"},{"key":"7475_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","volume":"21","author":"S Toldo","year":"2024","unstructured":"Toldo S, Abbate A. The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases. Nat Rev Cardiol. 2024;21:219\u201337.","journal-title":"Nat Rev Cardiol"},{"key":"7475_CR12","first-page":"329","volume":"73","author":"JH Wang","year":"2021","unstructured":"Wang JH, Liang H, Yu Y, Gao Q. Research progress on pyroptosis and cardiovascular diseases. Sheng Li Xue Bao. 2021;73:329\u201341.","journal-title":"Sheng Li Xue Bao"},{"key":"7475_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36614-w","volume":"14","author":"Y Wei","year":"2023","unstructured":"Wei Y, Lan B, Zheng T, Yang L, Zhang X, Cheng L, et al. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis. Nat Commun. 2023;14:929.","journal-title":"Nat Commun"},{"key":"7475_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580593","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y, Luo T, Weng A, Huang X, Yao Y, Fu Z, et al. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol. 2020;11:580593.","journal-title":"Front Immunol"},{"key":"7475_CR15","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.7150\/ijbs.46153","volume":"16","author":"K Hao","year":"2020","unstructured":"Hao K, Jiang W, Zhou M, Li H, Chen Y, Jiang F, et al. Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis. Int J Biol Sci. 2020;16:3163\u201373.","journal-title":"Int J Biol Sci"},{"key":"7475_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/14397595.2021.1899569","volume":"32","author":"J Tian","year":"2022","unstructured":"Tian J, Wang B, Xie B, Liu X, Zhou D, Hou X, et al. Pyroptosis inhibition alleviates potassium oxonate- and monosodium urate-induced gouty arthritis in mice. Mod Rheumatol. 2022;32:221\u201330.","journal-title":"Mod Rheumatol"},{"key":"7475_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.tins.2019.11.005","volume":"43","author":"BA McKenzie","year":"2020","unstructured":"McKenzie BA, Dixit VM, Power C. Fiery cell death: pyroptosis in the central nervous system. Trends Neurosci. 2020;43:55\u201373.","journal-title":"Trends Neurosci"},{"key":"7475_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526:660\u20135.","journal-title":"Nature"},{"key":"7475_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017;42:245\u201354.","journal-title":"Trends Biochem Sci"},{"key":"7475_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature18590","volume":"535","author":"J Ding","year":"2016","unstructured":"Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016;535:111\u20136.","journal-title":"Nature"},{"key":"7475_CR21","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/cr.2015.139","volume":"25","author":"WT He","year":"2015","unstructured":"He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion. Cell Res. 2015;25:1285\u201398.","journal-title":"Cell Res"},{"key":"7475_CR22","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nature15541","volume":"526","author":"N Kayagaki","year":"2015","unstructured":"Kayagaki N, Stowe IB, Lee BL, O\u2019Rourke K, Anderson K, Warming S, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526:666\u201371.","journal-title":"Nature"},{"key":"7475_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2019.04.017","volume":"51","author":"Z Liu","year":"2019","unstructured":"Liu Z, Wang C, Yang J, Zhou B, Yang R, Ramachandran R, et al. Crystal structures of the full-length murine and human gasdermin D reveal mechanisms of autoinhibition, lipid binding, and oligomerization. Immunity. 2019;51:43\u20139.e4.","journal-title":"Immunity"},{"key":"7475_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature18629","volume":"535","author":"X Liu","year":"2016","unstructured":"Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153\u20138.","journal-title":"Nature"},{"key":"7475_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","volume":"180","author":"K Wang","year":"2020","unstructured":"Wang K, Sun Q, Zhong X, Zeng M, Zeng H, Shi X, et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell. 2020;180:941\u201355.e20.","journal-title":"Cell"},{"key":"7475_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06013-6","volume":"14","author":"X Chu","year":"2023","unstructured":"Chu X, Xiao X, Wang G, Uosef A, Lou X, Arnold P, et al. Gasdermin D-mediated pyroptosis is regulated by AMPK-mediated phosphorylation in tumor cells. Cell Death Dis. 2023;14:469.","journal-title":"Cell Death Dis"},{"key":"7475_CR27","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.15252\/embj.201694696","volume":"35","author":"L Sborgi","year":"2016","unstructured":"Sborgi L, Ruhl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016;35:1766\u201378.","journal-title":"EMBO J"},{"key":"7475_CR28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/cmi.2016.15","volume":"13","author":"JS Bednash","year":"2016","unstructured":"Bednash JS, Mallampalli RK. Regulation of inflammasomes by ubiquitination. Cell Mol Immunol. 2016;13:722\u20138.","journal-title":"Cell Mol Immunol"},{"key":"7475_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605.","journal-title":"Cell Death Differ"},{"key":"7475_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/febs.15118","volume":"287","author":"G Lopez-Castejon","year":"2020","unstructured":"Lopez-Castejon G. Control of the inflammasome by the ubiquitin system. FEBS J. 2020;287:11\u201326.","journal-title":"FEBS J"},{"key":"7475_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22979-3","volume":"12","author":"SL Vijayaraj","year":"2021","unstructured":"Vijayaraj SL, Feltham R, Rashidi M, Frank D, Liu Z, Simpson DS, et al. The ubiquitylation of IL-1beta limits its cleavage by caspase-1 and targets it for proteasomal degradation. Nat Commun. 2021;12:2713.","journal-title":"Nat Commun"},{"key":"7475_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62\u201373.","journal-title":"Cell"},{"key":"7475_CR33","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1074\/jbc.RA119.011622","volume":"295","author":"T Douglas","year":"2020","unstructured":"Douglas T, Saleh M. Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation. J Biol Chem. 2020;295:5216\u201328.","journal-title":"J Biol Chem"},{"key":"7475_CR34","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-04020-1","volume":"599","author":"Z Li","year":"2021","unstructured":"Li Z, Liu W, Fu J, Cheng S, Xu Y, Wang Z, et al. Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11. Nature. 2021;599:290\u20135.","journal-title":"Nature"},{"key":"7475_CR35","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1016\/j.cell.2021.04.036","volume":"184","author":"JM Hansen","year":"2021","unstructured":"Hansen JM, de Jong MF, Wu Q, Zhang LS, Heisler DB, Alto LT, et al. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions. Cell. 2021;184:3178\u201391.e18.","journal-title":"Cell"},{"key":"7475_CR36","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.chom.2021.08.010","volume":"29","author":"G Luchetti","year":"2021","unstructured":"Luchetti G, Roncaioli JL, Chavez RA, Schubert AF, Kofoed EM, Reja R, et al. Shigella ubiquitin ligase IpaH7.8 targets gasdermin D for degradation to prevent pyroptosis and enable infection. Cell Host Microbe. 2021;29:1521\u201330.e10.","journal-title":"Cell Host Microbe"},{"key":"7475_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13046-022-02533-9","volume":"41","author":"M Di","year":"2022","unstructured":"Di M, Miao J, Pan Q, Wu Z, Chen B, Wang M, et al. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis. J Exp Clin Cancer Res. 2022;41:328.","journal-title":"J Exp Clin Cancer Res"},{"key":"7475_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04553-x","volume":"13","author":"Y Shi","year":"2022","unstructured":"Shi Y, Yang Y, Xu W, Shi D, Xu W, Fu X, et al. E3 ubiquitin ligase SYVN1 is a key positive regulator for GSDMD-mediated pyroptosis. Cell Death Dis. 2022;13:106.","journal-title":"Cell Death Dis"},{"key":"7475_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen CE, Wolberger C. New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 2014;21:301\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"7475_CR40","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159\u201392.","journal-title":"Annu Rev Biochem"},{"key":"7475_CR41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0092-8674(94)90532-0","volume":"78","author":"M Rothe","year":"1994","unstructured":"Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 1994;78:681\u201392.","journal-title":"Cell"},{"key":"7475_CR42","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gky1159","volume":"47","author":"PV Hornbeck","year":"2019","unstructured":"Hornbeck PV, Kornhauser JM, Latham V, Murray B, Nandhikonda V, Nord A, et al. 15 years of PhosphoSitePlus(R): integrating post-translationally modified sites, disease variants and isoforms. Nucleic Acids Res. 2019;47:D433\u2013D41.","journal-title":"Nucleic Acids Res"},{"key":"7475_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/s41594-018-0084-y","volume":"25","author":"V Akimov","year":"2018","unstructured":"Akimov V, Barrio-Hernandez I, Hansen SVF, Hallenborg P, Pedersen AK, Bekker-Jensen DB, et al. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018;25:631\u201340.","journal-title":"Nat Struct Mol Biol"},{"key":"7475_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00011-016-0937-y","volume":"65","author":"CL Lakshmikanth","year":"2016","unstructured":"Lakshmikanth CL, Jacob SP, Chaithra VH, de Castro-Faria-Neto HC, Marathe GK. Sepsis: in search of cure. Inflamm Res. 2016;65:587\u2013602.","journal-title":"Inflamm Res"},{"key":"7475_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/cei.12971","volume":"189","author":"KF Esquerdo","year":"2017","unstructured":"Esquerdo KF, Sharma NK, Brunialti MKC, Baggio-Zappia GL, Assuncao M, Azevedo LCP, et al. Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors. Clin Exp Immunol. 2017;189:232\u201340.","journal-title":"Clin Exp Immunol"},{"key":"7475_CR46","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41423-022-00905-x","volume":"19","author":"X Wei","year":"2022","unstructured":"Wei X, Xie F, Zhou X, Wu Y, Yan H, Liu T, et al. Role of pyroptosis in inflammation and cancer. Cell Mol Immunol. 2022;19:971\u201392.","journal-title":"Cell Mol Immunol"},{"key":"7475_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109595","volume":"121","author":"Y Fang","year":"2020","unstructured":"Fang Y, Tian S, Pan Y, Li W, Wang Q, Tang Y, et al. Pyroptosis: a new frontier in cancer. Biomed Pharmacother. 2020;121:109595.","journal-title":"Biomed Pharmacother"},{"key":"7475_CR48","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B, Nemmara VV, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020;369:1633\u20137.","journal-title":"Science"},{"key":"7475_CR49","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adn1452","volume":"9","author":"A Balasubramanian","year":"2024","unstructured":"Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, et al. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol. 2024;9:eadn1452.","journal-title":"Sci Immunol"},{"key":"7475_CR50","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y, Zhao J, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020;21:736\u201345.","journal-title":"Nat Immunol"},{"key":"7475_CR51","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.drudis.2021.04.029","volume":"26","author":"ZQ Li","year":"2021","unstructured":"Li ZQ, Chen X, Wang Y. Small molecules targeting ubiquitination to control inflammatory diseases. Drug Discov Today. 2021;26:2414\u201322.","journal-title":"Drug Discov Today"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07475-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07475-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T14:00:54Z","timestamp":1742220054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07475-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7475"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07475-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4907061\/v1","asserted-by":"object"}]},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"181"}}